![Alison Bailey](/-/media/Non-Clinical/Images/2019/11/08/Bailey-Alison-600x600.jpg)
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novo Nordisk(SIGNIFICANT) OTHER FINANCIAL BENEFIT: OptumRx(MODEST)
CONSULTING FEES/HONORARIA: Novo Nordisk(SIGNIFICANT) OTHER FINANCIAL BENEFIT: OptumRx(MODEST)
© 2024 American College of Cardiology Foundation. All rights reserved.